Klotho Neurosciences, Inc. (KLTO NASDAQ) stock market data APIs
$0.5516
0.03(5.4%)
as of September 18, 2025
Try our APIs with
free plan!
Klotho Neurosciences, Inc. Financial Data Overview
Price chart is built with
Anychart
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska.
Prev. Close
0.5516
Open
0.5775
High
0.5795
Low
0.5516
52 wk Range
0.114-2.45
Market Cap
34 983 K
Shares Outstanding
61 374 K
EPS
-0.1206
Beta
2.509
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Klotho Neurosciences, Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Klotho Neurosciences, Inc. data using free add-ons & libraries
Get Klotho Neurosciences, Inc. Fundamental Data
Klotho Neurosciences, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Klotho Neurosciences, Inc. News
New
Klotho Neurosciences advances ALS treatment candidate toward clinical trials
NEW YORK - Klotho Neurosciences, Inc. (NASDAQ:KLTO), a biotechnology company with a current market capitalization of $45.33 million, has received Orphan Drug Designation from the FDA for its KLTO-202 ...
Form 8K Klotho Neuroscience Inc For: 12 August
Weekly Recap: 12 Health Press Releases You Need to See
A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Sanofi's $1.6B acquisition and a groundbreaking surgical nerve treatment for veterans. NEW YORK, July...
Klotho Neurosciences Partners With AAVnerGene To Accelerate Cost-Effective Gene Therapy Development
(RTTNews) - Klotho Neurosciences, Inc. (KLTO) has formed a strategic partnership with Maryland-based biotech firm AAVnerGene Inc., aiming to enhance the manufacturing of its gene therapy candidates us...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
